These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

666 related articles for article (PubMed ID: 24322569)

  • 1. Overdiagnosis in low-dose computed tomography screening for lung cancer.
    Patz EF; Pinsky P; Gatsonis C; Sicks JD; Kramer BS; Tammemägi MC; Chiles C; Black WC; Aberle DR;
    JAMA Intern Med; 2014 Feb; 174(2):269-74. PubMed ID: 24322569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening for Lung Cancer With Low-Dose Computed Tomography: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
    Jonas DE; Reuland DS; Reddy SM; Nagle M; Clark SD; Weber RP; Enyioha C; Malo TL; Brenner AT; Armstrong C; Coker-Schwimmer M; Middleton JC; Voisin C; Harris RP
    JAMA; 2021 Mar; 325(10):971-987. PubMed ID: 33687468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Computed tomography screening for lung cancer: has it finally arrived? Implications of the national lung screening trial.
    Aberle DR; Abtin F; Brown K
    J Clin Oncol; 2013 Mar; 31(8):1002-8. PubMed ID: 23401434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lung Cancer Incidence and Mortality with Extended Follow-up in the National Lung Screening Trial.
    National Lung Screening Trial Research Team
    J Thorac Oncol; 2019 Oct; 14(10):1732-1742. PubMed ID: 31260833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of low-dose computed tomography (LDCT) screening on lung cancer-related mortality.
    Bonney A; Malouf R; Marchal C; Manners D; Fong KM; Marshall HM; Irving LB; Manser R
    Cochrane Database Syst Rev; 2022 Aug; 8(8):CD013829. PubMed ID: 35921047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thyroid Incidentalomas in Association With Low-Dose Computed Tomography in the National Lung Screening Trial.
    Loomans-Kropp HA; Dunn BK; Kramer BS; Pinsky P
    Am J Epidemiol; 2020 Jan; 189(1):27-33. PubMed ID: 31595954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics and Outcomes of Lung Cancers Detected on Low-Dose Lung Cancer Screening CT.
    Zhang EW; Shepard JO; Kuo A; Chintanapakdee W; Keane F; Gainor JF; Mino-Kenudson M; Lanuti M; Lennes IT; Digumarthy SR
    Cancer Epidemiol Biomarkers Prev; 2021 Aug; 30(8):1472-1479. PubMed ID: 34108138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Baseline findings of a randomized feasibility trial of lung cancer screening with spiral CT scan vs chest radiograph: the Lung Screening Study of the National Cancer Institute.
    Gohagan J; Marcus P; Fagerstrom R; Pinsky P; Kramer B; Prorok P;
    Chest; 2004 Jul; 126(1):114-21. PubMed ID: 15249451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of postscreening follow-up time and participant characteristics on estimates of overdiagnosis from lung cancer screening trials.
    Li M; Zhang L; Charvat H; Callister ME; Sasieni P; Christodoulou E; Kaaks R; Johansson M; Carvalho AL; Vaccarella S; Robbins HA
    Int J Cancer; 2022 Nov; 151(9):1491-1501. PubMed ID: 35809038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-dose computed tomography for lung cancer screening in high-risk populations: a systematic review and economic evaluation.
    Snowsill T; Yang H; Griffin E; Long L; Varley-Campbell J; Coelho H; Robinson S; Hyde C
    Health Technol Assess; 2018 Nov; 22(69):1-276. PubMed ID: 30518460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Inclusion of More Black Individuals in Lung Cancer Screening With Reduced Mortality.
    Prosper AE; Inoue K; Brown K; Bui AAT; Aberle D; Hsu W
    JAMA Netw Open; 2021 Aug; 4(8):e2119629. PubMed ID: 34427681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimating overdiagnosis in low-dose computed tomography screening for lung cancer: a cohort study.
    Veronesi G; Maisonneuve P; Bellomi M; Rampinelli C; Durli I; Bertolotti R; Spaggiari L
    Ann Intern Med; 2012 Dec; 157(11):776-84. PubMed ID: 23208167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Baseline results of the Depiscan study: a French randomized pilot trial of lung cancer screening comparing low dose CT scan (LDCT) and chest X-ray (CXR).
    Blanchon T; Bréchot JM; Grenier PA; Ferretti GR; Lemarié E; Milleron B; Chagué D; Laurent F; Martinet Y; Beigelman-Aubry C; Blanchon F; Revel MP; Friard S; Rémy-Jardin M; Vasile M; Santelmo N; Lecalier A; Lefébure P; Moro-Sibilot D; Breton JL; Carette MF; Brambilla C; Fournel F; Kieffer A; Frija G; Flahault A;
    Lung Cancer; 2007 Oct; 58(1):50-8. PubMed ID: 17624475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Computed Tomographic Screening Promotion With Lung Cancer Overdiagnosis Among Asian Women.
    Gao W; Wen CP; Wu A; Welch HG
    JAMA Intern Med; 2022 Mar; 182(3):283-290. PubMed ID: 35040922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Performance of Lung-RADS in the National Lung Screening Trial: a retrospective assessment.
    Pinsky PF; Gierada DS; Black W; Munden R; Nath H; Aberle D; Kazerooni E
    Ann Intern Med; 2015 Apr; 162(7):485-91. PubMed ID: 25664444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival Following Detection of Stage I Lung Cancer by Screening in the National Lung Screening Trial.
    Gierada DS; Pinsky PF
    Chest; 2021 Feb; 159(2):862-869. PubMed ID: 32822676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Airflow Limitation and Histology Shift in the National Lung Screening Trial. The NLST-ACRIN Cohort Substudy.
    Young RP; Duan F; Chiles C; Hopkins RJ; Gamble GD; Greco EM; Gatsonis C; Aberle D
    Am J Respir Crit Care Med; 2015 Nov; 192(9):1060-7. PubMed ID: 26199983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lung cancer screening overdiagnosis: reports of overdiagnosis in screening for lung cancer are grossly exaggerated.
    Mortani Barbosa EJ
    Acad Radiol; 2015 Aug; 22(8):976-82. PubMed ID: 25772581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolonged lung cancer screening reduced 10-year mortality in the MILD trial: new confirmation of lung cancer screening efficacy.
    Pastorino U; Silva M; Sestini S; Sabia F; Boeri M; Cantarutti A; Sverzellati N; Sozzi G; Corrao G; Marchianò A
    Ann Oncol; 2019 Jul; 30(7):1162-1169. PubMed ID: 30937431
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 34.